

































259 LETTERS TO EDITOR 
Hillman RS, Ault KA, Rinder HM, editors.
Hematology in clinical practice: A guide to
diagnosis and management. 4th ed. New York:
McGraw-Hill Professional; 2005. p. 137-50.
RECURRENT HEMATOSPERMIA 
DUE TO ASPIRIN 
Sir, 
The presence of  b lood in the semen  
is called hematospermia and represents 
1 %  o f  a l l  a n d r o l o g i c  a n d  u r o l o g i c
symptoms.[1] Hematospermia is an uncommon 
clinical condition that usually follows a painless, 
benign and self-limited course; but it can be a 
source of considerable fear and anxiety that 
is uncommonly associated with significant 
underlying pathology and is mostly considered 
to be idiopathic in nature.[2] Hematospermia 
is classiﬁ ed by its cause, which may be an 
inﬂ ammation or infection, an obstruction or cyst, 
a vascular abnormality, a systemic disease, a 
tumor or an idiopathic condition.[3] Management 
with appropriate clinical evaluation, watchful 
waiting, and reassurance often sufﬁ ces without 
further diagnostic workup or treatment.[2]  
A 32-year-old man referred to our hospital 
in Gorgan, north of Iran; he presented with 
recurrent painless hematospermia of 18 
months’ duration. He did not have any history 
of urinary tract infections; sexually transmitted 
diseases; prolonged and intense masturbation 
or sexual intercourse; hypertension; renal, liver 
or bleeding disorders; abdominal trauma or 
surgery. He did not report erectile dysfunction 
(International Index of Erectile Function 
score, 25). The ﬁ ndings of general physical 
examination of the patient were normal. No 
evidence of trauma or self-instrumentation 
 
in the urogenital region was found. The
prostate was normal in size and consistency, 
and no abnormal masses were palpable on
digital examination. External genitalia, testes, 
epididymis, cord and penile urethra were
normal. Seminal vesicles were not palpable.
The urethral meatus was evaluated, and
no evidence of trauma, condylomata and
phimosis was found. Hematologic studies
(PT, PTT, CBC and ESR), urinalysis, urine
culture, semen analysis and semen culture
were done, and none of these revealed any
abnormality. Results of PSA test, mycobacterial
cultures, urethral cultures for gonorrhea
and chlamydia, transrectal ultrasound of the
prostate and abdominopelvic sonography
were normal. Empirical treatment with an
antibiotic (quinolone) and an anti-inﬂammatory 
medication (selective COX-2 inhibitor) was
administered, to which there was no response. 
The patient was evaluated for epididymitis,
prostitis, urethritis, HIV, condylomata, urinary 
stones, liver cirrhosis, arterial hypertension,
genitourinary TB and hematologic disease, and
he was normal in all these assessments; so the
specialists reassured him that this condition
was benign and self limited. Finally, he reported
ASA consumption due to hemoconcentration
2 years ago. ASA effect as a causation of
hematospermia was suspected. We carried
out coagulation tests (PT, PTT, BT, and CT), 
which, again, were normal except for BT,
which was slightly prolonged. So ASA was
discontinued and hematospermia stopped and 
was not found to appear during the follow-ups 
in the following 6 months. For conﬁ rmation of 
the mentioned diagnosis, ASA was restarted
and hematospermia reappeared. We can
affirm this cause-and-effect relationship to
some extent because of the reappearance of 
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hematospermia when ASA was restarted. The 
etiology in relation to this ﬁnding may be that 
hematospermia could have been caused by
micro-trauma after ejaculatory contractions,
and aspirin may have been a contributing
factor by damaging the integrity of a congested 
mucosa or interfering with platelet function,
which could have produced hematospermia.
The importance of this case presentation is
that no similar reports about the side effects of 
aspirin are found in the literature according to 
our search. 
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REPORTING ETHICAL 
PROCESSES: SURVEY OF 
‘INSTRUCTIONS TO AUTHORS’ 
PROVIDED BY INDIAN 
JOURNALS 
Dear Sir, 
Ethical approval by an independent review
board and written informed consent given by 
Indian J Med Sci, Vol. 63, No. 6, June 2009 
research participants are the two cornerstones
of ethical research. A previous study has noted
that only 30% of manuscripts published in 2
Indian pediatric journals have mentioned ethics
committee approval (ECA), and only 47% of
prospective study reports have indicated that 
informed consent (IC) was obtained.[1] Because
authors prepare manuscripts on the basis of
guidelines provided by journals, we examined
if Indian medical journals provide explicit
guidelines to their contributors in this regard.
We obtained a list of Indian journals from
Google (www.google.co.in/), PubMed (http:// 
www.ncbi.nlm.nih.gov/pubmed/), MedIndia
(www.medindia.net/doctors/journals/indian/ 
indian_journals.asp?alpha=j) and the National 
Informatics Center (http://indmed.nic.in/). The 
journals belonging to streams of medicine
other than allopathy (modern medicine), like
those on Ayurveda, Siddha or Unani medicine,
and those whose ‘Instructions to authors/
contributors’ could not be located were excluded
from analysis. Also, newsletters, periodicals
and journals that published only reviews were
excluded. The ‘Instructions to authors’ were
read by all the three authors of this article
to determine whether ethical aspects were
mentioned and whether the guidelines explicitly
required a mention of ECA and approval
from the animal ethics committee, obtaining
IC and assent, and that research had to be
carried out in accordance with the national
guidelines provided by the Indian Council of
Medical Research, 2006,[2] or Declaration of
Helsinki.[3] From a list of 340 Indian medical
periodicals (including journals, bulletins and
other scientiﬁc publications), 240 were excluded
from the analysis as their print or electronic
versions could not be located (166) or they
